AI Biomed PredictionsNMRA – Phase 3 Redemption Window Nears for Beaten-Down Neumora Shares ScanScor Admin / May 10, 2026
AI Biomed PredictionsTNYA – ASGCT TN-401 data could decide Tenaya’s next sharp rerating ScanScor Admin / May 2, 2026
AI Biomed PredictionsPYPD – PolyPid Nears NDA Completion With Regulatory Repricing Potential ScanScor Admin / May 2, 2026
AI Biomed PredictionsPRQR – AX-0810 Human Proof-of-Mechanism Could Reprice ProQR Quickly ScanScor Admin / May 2, 2026
AI Biomed PredictionsOSTX – OSTX Faces Its Defining FDA Pathway Test This Month ScanScor Admin / May 2, 2026
AI Biomed PredictionsOBIO – HRS AVIM data could spark OBIO’s next revaluation ScanScor Admin / May 2, 2026
AI Biomed PredictionsINO – Depressed Inovio May Rebound on FDA Review Reassurance ScanScor Admin / May 2, 2026
AI Biomed PredictionsACXP – Microcap ACXP hinges on proof ibezapolstat development is truly starting ScanScor Admin / May 2, 2026
AI Biomed PredictionsNRSN – May regulatory clarity could decide NeuroSense’s next ALS breakout ScanScor Admin / May 2, 2026
AI Biomed PredictionsHIND – Phase 3 clarity could awaken this forgotten microcap biotech ScanScor Admin / April 30, 2026
